The detergent sodium dodecyl sulfate is a wellknown inducer of irritant contact dermatitis. In this study we show that sodium dodecyl sulfate induces the serine proteinase inhibitor, plasminogen activator inhibitor type 2, in epidermal keratinocytes. The enhancement in plasminogen activator inhibitor type 2 mRNA and antigen is observed both when sodium dodecyl sulfate is applied topically to normal human skin as well as when it is added to the growth medium of cultured human keratinocytes. In vitro, plasminogen activator inhibitor type 2 mRNA is increased within 4±8 h after addition of the detergent, and the increase in plasminogen activator inhibitor type 2 antigen occurs slightly later. The enhancing effect of sodium dodecyl sulfate on plasminogen activator inhibitor type 2 is not related to nonspeci®c cell lysis nor is it secondary to induction of tumor necrosis factor a. Similarities between our in vitro and in vivo ®ndings lead us to hypothesize that sodium dodecyl sulfate may exert its effect on epidermal plasminogen activator inhibitor type 2 via interaction with the keratinocyte. J Invest Dermatol 117: 647±653, 2001 P lasminogen activator inhibitor type 2 (PAI-2) is an unusual serine proteinase inhibitor (serpin) that is synthesized in high amounts in normal strati®ed squamous epithelia, including epidermis and oral epithelium (Hibino et al, 1988; Remold-O'Donnell, 1993; Lyons-Giordano et al, 1994; Kruithof et al, 1995; Risse et al, 1998 , 2000 , Kinnby et al, 1999 . PAI-2 is not ef®ciently secreted, as it lacks a consensus signal sequence, and thus it accumulates inside the keratinocyte and other cells (Belin et al, 1989; Wang and Jensen, 1998) . The intracellular localization of PAI-2 seems inconsistent with the fact that the known target proteinases for PAI-2 (i.e., urokinase and tissue type plasminogen activators) are both secreted enzymes. The discrepancy in localization between inhibitor and expected targets has led to speculation about the possible existence of one or more alternative, intracellular target proteinases, inhibition of which could constitute an intracellular function for PAI-2 in strati®ed squamous epithelia (Risse et al, 2000) . Alternatively, it cannot be ruled out that PAI-2 may play some kind of structural role, independent of its proteinase inhibitory activity.
Several lines of evidence have suggested that PAI-2 may have a role in normal epidermal differentiation. (i) In normal human and neonatal mouse epidermis, PAI-2 is synthesized predominantly in the super®cial, i.e., more differentiated, layers (Lyons-Giordano et al, 1994; Risse et al, 1998 Risse et al, , 2000 . (ii) PAI-2 antigen is concentrated around the periphery of keratinocytes in the granular layer (i.e., the most differentiated viable layer) of human epidermis. This localization is similar to the distribution of transglutaminase 1, which is the enzyme responsible for cross-linking proteins into the corni®ed envelope, the end product of keratinocyte terminal differentiation (Thacher and Rice, 1985; Lyons-Giordano et al, 1994; Risse et al, 2000) . (iii) PAI-2 is a substrate for transglutaminase and is incorporated into the corni®ed envelope of cultured human keratinocytes (Jensen et al, , 1995 Robinson et al, 1997) .
There is also evidence that PAI-2 expression is modulated during cutaneous wound repair. Epidermal PAI-2 mRNA is rapidly increased upon perturbation of normal mouse skin, e.g., by gentle plucking of hairs or by removing the stratum corneum with sticky tape (Jensen and Lavker, 1996) . High levels of PAI-2 mRNA and antigen have been reported in keratinocytes that are expanding to cover an epidermal defect in human patients (Bechtel et al, 1998) . Consistent with these in vivo data, PAI-2 is expressed in all keratinocytes of early stage organotypic cultures, which resemble epithelia in the process of repair; however, PAI-2 expression is limited to the suprabasal keratinocyte layers when the cultures become highly strati®ed and differentiated, much like its expression pattern in normal epidermis (Chen et al, 1993; Bechtel et al, 1998) . Finally, PAI-2 is strongly increased upon incubation of keratinocyte cultures with tumor necrosis factor a (TNF-a), a proin¯ammatory stimulus (Wang and Jensen, 1998) .
To address further the regulation of PAI-2 during epidermal disruption, we have turned to a well-established model of irritant contact dermatitis, i.e., topical application of sodium dodecyl sulfate (SDS). Although quantitatively the responses of individual volunteers to SDS treatment are quite variable, several hallmark clinical effects are notable: disrupted barrier function, as measured by increased transepidermal water loss; erythema; increased epidermal thickness; and recruitment of in¯ammatory cells (Willis et al, 1993; Lee and Maibach, 1995) . Several mechanisms have been proposed for the cutaneous effects of SDS, including disruption of the stratum corneum lipid sheets, denaturation of proteins, and direct effects on keratinocytes (Elias, 1996; Fartasch et al, 1998; Welzel et al, 1998) . Evaluating the potential mechanisms of SDS action in an in vivo setting is fraught with dif®culty, leading to attempts to develop simpler models. In keratinocyte cultures, which do not form a functional barrier and do not have any in¯ammatory cell component, SDS is able to elicit some of the effects observed upon topical application in vivo (van Ruissen et al, 1998) . These ®ndings argue strongly that some of the effects of SDS on epidermis are mediated through direct effects on the keratinocytes. In this study, we have evaluated the effect of SDS on PAI-2 expression in normal volunteers and in human keratinocyte cultures.
MATERIALS AND METHODS
SDS treatment of human skin An occlusion patch saturated with 1% (35 mM) SDS was applied for 24 h to the lower back of six volunteers, followed by 3 mm punch biopsies (of three subjects) or shave biopsies (of three subjects) from the treated skin. Control skin that had been under an occlusion patch without SDS for the same period of time was biopsied concurrently from the same volunteers. For all subjects, biopsies were embedded in OCT compound (TissueTek; Sakura Finetek USA, Terrance, CA) with liquid nitrogen, and the tissue was sectioned at 5 mm for immunohistochemistry. For three of the subjects, each biopsy was divided in half, with one half embedded as above and the other half ®xed for 24 h in 4% paraformaldehyde, processed for paraf®n sections, and utilized for in situ hybridization.
Calculation of epidermal SDS concentration following patch application We utilized the values in two published studies in which the amount of SDS in the epidermis was assayed after topical application of 1% SDS under occlusion for 24 h. Speci®cally, in hairless rat skin, a concentration of 6.3 mmol SDS per gram of tissue was measured in the epidermis under the treatment patch (Patil et al, 1995) . If we assume that a gram of tissue is equivalent to 1 ml of water, then we can estimate that the average concentration of SDS in the epidermis was 6.3 mM (1.8 mg per ml). In another study, when 60 ml of 1% SDS was applied under occlusion for 24 h to human cadaver skin, an average of 32% of the applied dose of SDS was recovered in the epidermis under the 1.8 cm 2 treatment patch (Fullerton et al, 1994) . To estimate the concentration of SDS in the epidermis in this study, we have assumed that the thickness of human epidermis is 46 mm (Nickoloff and Naidu, 1993) , which allows us to estimate the volume of epidermal tissue in which SDS was recovered (i.e., 8 ml). Using these estimates, we calculate that the concentration of SDS in the epidermis was approximately 24 mg per ml (83 mM).
In situ hybridization In situ hybridization was carried out as described previously, using 35 S-labeled antisense or sense cRNA probes transcribed from a 463 bp PstI/XbaI fragment, spanning nucleotides 327±790 of human PAI-2 cDNA (Lyons-Giordano et al, 1994; Risse et al, 2000) .
Immunohistochemistry Frozen sections were ®xed in acetone at ±20°C for 10 min; washed in phosphate-buffered saline (PBS); preincubated in 10% normal horse serum in PBS for 30 min; and incubated 60 min at room temperature with primary antibody diluted to 3 mg per ml in 10% normal horse serum in PBS, as described previously (Risse et al, 2000) . Primary antibodies were mouse antihuman PAI-2 IgG (#3750; American Diagnostica, Greenwich, CT) or, as a control, normal mouse IgG. After washing with PBS, the sections were incubated for 60 min at room temperature with horse antimouse biotinylated antibody (Vector Laboratories, Burlingame, CA) diluted 1:200 in 10% normal horse serum/PBS. After again washing with PBS, the sections were incubated for 45 min with ABC reagent (Elite Vectastain kit, Vector Laboratories), prepared as recommended by the manufacturer. The stain was visualized by incubation with 3,3¢-diaminobenzidine (DAB) solution; a 10 mg tablet (#5905, Sigma Chemical, St. Louis, MO) was dissolved in 15 ml 0.1 M Tris-HCl pH 7.6 with 120 ml of 3% H 2 O 2 . Incubation times with DAB ranged from 3 to 7 min. Slides were dehydrated and mounted in Permount (Fisher Chemicals, Fair Lawn, NJ) .
Keratinocyte cultures Keratinocyte cultures were initiated from neonatal foreskin and propagated in serum-free MCDB medium with low (i.e., 30 mM) Ca 2+ and additives, as previously described (Ando and Jensen, 1996) . For experiments, second or third passage keratinocytes were seeded into six-well culture dishes and grown until approximately 60%±70% con¯uent. At this time, bovine pituitary extract (BPE) was omitted from the culture medium and incubation was continued until the cultures became con¯uent, which usually took 48 h. BPE was omitted from the culture medium at subcon¯uence and through the rest of the experiment because preliminary experiments showed that this additive had an enhancing effect on PAI-2 expression. In most experiments, except as noted, when the cultures reached con¯uence, the concentration of Ca 2+ in the medium was elevated to 1.0 mM in order to induce strati®cation and differentiation. After 48 h in medium with elevated Ca 2+ , the keratinocytes were treated with SDS (ultraPURE, 99.5% purity, GibcoBRL, Grand Island, NY) at concentrations ranging from 3.0 to 25.0 mg per ml (10±87 mM) for 2±24 h. These concentrations are well below the critical micelle concentration for SDS, which is approximately 1 mM in physiologic saline (Tanford, 1980) . RNase protection Total cellular RNA from keratinocyte cultures was extracted using the Purescript RNA Isolation Kit (Gentra Systems, Minneapolis, MN). PAI-2 mRNA was quanti®ed by RNase protection, using the Ambion RPA III RNase Protection Assay kit (Ambion, Austin, TX). Biotinylated antisense riboprobes were prepared from the 463 bp Pst I/Xba I fragment of human PAI-2 cDNA described above under in situ hybridization, and from a 103 bp fragment of human cyclophilin, spanning nucleotides 38±140 (Ambion). Total cellular RNA (3.5 mg) was hybridized with 150 pg of biotinylated probe overnight at 42°C. Unhybridized RNA was digested with RNAse T1 (5000 units per ml). Protected RNA fragments were precipitated and resolved by gel electrophoresis using 5% polyacrylamide with 8 M urea, followed by electroblot transfer to nylon membrane (Roche Molecular Biochemicals, Indianapolis, IN). After ultraviolet crosslinking of the membranes, protected mRNA was detected with the Brightstar Bio Detect Kit (Ambion) using streptavidin-alkaline phosphatase and CDP-Star chemiluminescence.
Immunoblot Cell-associated protein was extracted by scraping keratinocyte cultures into 0.1 M Tris-HCl pH 8.1 with 0.2% Triton X-100 (Tris/Triton buffer; 200 ml per 9.5 cm 2 well). In several control experiments, the remaining pellet after Tris/Triton extraction was subjected to a more rigorous extraction in 25 mM Tris-HCl, pH 7.6, 1 mM MgCl 2 , 1 mM ethyleneglycol-bis(b-aminoethyl ether)-N,N,N¢,N¢-tetraacetic acid, 1% Triton X-100, and 1% SDS. Cellular debris was removed by centrifugation at 16,000g, and samples were stored at ±70°C. Total protein concentrations were determined using Pierce BCA Protein Assay Reagents (Pierce, Rockford, IL). Samples containing 1 mg of total protein were resolved by 9.5% denaturing polyacrylamide gel electrophoresis and then transferred to nitrocellulose membrane. Immunoblotting was performed with mouse antihuman PAI-2 IgG (#3750; American Diagnostica) diluted to 5 mg per ml or with rabbit antihuman involucrin antibody (BT601; Biomedical Technologies, Stoughton, MA), diluted 1:100 in 5% dry milk in Tris-buffered saline (20 mM Tris-HCl pH 7.6, 0.137 M NaCl) containing 0.2% Tween 20 (Sigma). Bands were visualized using horseradish peroxidase linked sheep antimouse IgG and ECL (both from Amersham Pharmacia Biotech, Piscataway, NJ). We consistently observed a 41 kDa band in the Tris/ Triton extracts, consistent with the nonglycosylated form of PAI-2. No additional PAI-2 was extracted by subsequent treatment with SDScontaining buffer. No detectable corni®ed envelopes were formed under the culture conditions utilized in this study, so PAI-2 accumulation in such structures (Jensen et al, 1995) cannot complicate interpretation of the results.
Quanti®cation of non-speci®c cell lysis To consider the possibility of nonspeci®c cell lysis induced by treatment of keratinocyte cultures with SDS, the release of lactate dehydrogenase (LDH) from cells was quanti®ed. Conditioned media from control and SDS-treated cultures were assayed using the Promega CytoTox96 Non-Radioactive Cytotoxicity Assay kit (#G1780; Promega, Madison, WI), following the manufacturer's protocol. Conditioned media from keratinocyte cultures incubated without and with SDS at varying concentrations were mixed with freshly reconstituted substrate mix (50 ml each) and incubated in the dark for 30 min at room temperature. The enzymatic reaction was terminated by addition of 50 ml per sample of stop solution, and absorbance at 490 nm was recorded using a microtiter plate reader. Control keratinocyte wells were lyzed by repeated freeze±thaw; serial dilutions of this lysate were included in the assay to determine the maximal LDH release. Background readings were determined using culture medium that had never been incubated with cells. Cytotoxicity in a given sample was calculated using the following formula: TNF-a enzyme-linked immunosorbent assay (ELISA) and treatment of cultures with anti-TNF-a antibody A human TNFa ELISA kit was purchased (DuoSet #DY210; R&D Systems, Minneapolis, MN). The assay was carried out as described by the manufacturer except that peroxidase substrate was purchased from Kirkegaard & Perry (1 component TMB microwell #50±76±18; Gaithersburg, MD). Because the levels of SDS added to the culture media interfered with the assay, conditioned media were dialyzed overnight against PBS prior to ELISA.
In one group of experiments, keratinocyte cultures were treated with SDS in the presence of 10 mg per ml of a neutralizing monoclonal antibody to TNF-a (catalog #MAB210; R&D Systems).
RESULTS

SDS induces PAI-2 in epidermis in vivo
To evaluate the effect of SDS on PAI-2 expression in vivo, SDS was applied under occlusion for 24 h to six normal human volunteers. Histologic examination of the SDS-treated skin consistently revealed compaction of the stratum corneum, with variable dissociation of the upper corni®ed layers, leaving a thin, dense layer of corneocytes. In all subjects, we observed a mild in¯ammatory in®ltrate, consisting mostly of mononuclear cells, localized just beneath the basement membrane and occasionally within the epidermis. In four of six subjects, the epidermis showed thickening with varying degrees of spongiosis, mostly within the stratum spinosum. These same four subjects also demonstrated some acantholysis, in one case displaying signs of beginning dyskeratosis. These observations, including the variability among normal subjects with regard to extent of response to SDS, are consistent with previous reports (Lee and Maibach, 1995) .
To evaluate the effect of SDS on PAI-2 expression in vivo, immunohistochemical staining and in situ hybridization were carried out on control and SDS-treated biopsies from the same individuals. As we have previously shown, in normal, control human epidermis, PAI-2 antigen was predominantly localized in the granular layer, where it was concentrated along the periphery of the cells (Fig 1A) . In SDS-treated skin from four of six subjects, we detected an increase in the number of epidermal layers exhibiting PAI-2 staining, with positive cells extending well into the spinous layers (Fig 1B, C) , which in control skin did not contain detectable Figure 2 . Expression of epidermal PAI-2 mRNA was induced after SDS treatment of normal human skin. Paraf®n sections of normal human skin from donor #2, untreated (A, C) or SDS treated (B, D), were processed for in situ hybridization using antisense or sense riboprobes to PAI-2. Scale bar: 100 mm. PAI-2 antigen. In two of six cases this extension of PAI-2 staining was observed in most ®elds throughout the biopsy ( Fig 1B) ; however, in the two other cases, the increase in PAI-2 staining was limited to focal areas within the epidermis (Fig 1C) . Regions of most extensive PAI-2 staining were present in the biopsies with the most obvious histologic changes. Two subjects showed no effect of SDS on the staining pattern for PAI-2.
In situ hybridization for PAI-2 mRNA was performed with biopsies from three subjects. In untreated skin, the signal for PAI-2 mRNA was uniformly weak but concentrated in the granular layer, as observed previously (Risse et al, 2000 ; Fig 2A) . In the subject whose epidermis showed the greatest SDS response histologically, PAI-2 mRNA signal was dramatically increased (Fig 2B) . The strongest increase of PAI-2 mRNA was found in the keratinocytes adjacent to epidermal regions with clear signs of epidermal disruption, e.g. spongiosis and acantholysis. More modest increases were detected in other ®elds throughout the biopsy, with signal generally concentrated in the spinous and basal layers. The other two subjects showed weaker PAI-2 mRNA induction after SDS, with only focal regions of increased PAI-2 mRNA signal compared to control biopsies. Thus, topical treatment with SDS for 24 h induced focal increases of PAI-2 mRNA in the basal and spinous layers and of PAI-2 antigen in the spinous layers. The fact that we do not detect increased PAI-2 antigen in the basal layer, in spite of PAI-2 mRNA increases, may indicate some post-transcriptional inhibitory regulation speci®c to the basal cells.
SDS induces PAI-2 in cultured keratinocytes
In most of the following studies to determine the effect of SDS on keratinocyte PAI-2 in vitro, we used a culture model that was strati®ed and differentiated. Keratinocyte cultures were grown to con¯uence; then the Ca 2+ concentration in the medium was elevated to 1.0 mM for two more days of incubation, in order to generate cultures containing four to six cell layers expressing numerous differentiation markers (Jensen et al, 1997) . Initially, SDS was tested at concentrations ranging from 3 to 25 mg per ml (10±87 mM) for incubations of 16 h (for RNase protection) or 24 h (for immunoblot). SDS at 3 mg per ml led to an increase in PAI-2 mRNA ( Fig 3A) ; a further increase in PAI-2 mRNA was observed at 6 mg per ml SDS, which represented a plateau value maintained up to 10±12.5 mg per ml SDS, depending upon the culture. Little to no effect of SDS was detectable on cyclophilin mRNA, which was included as a control. SDS also induced a concentration-dependent increase in PAI-2 antigen. The maximal increase was observed at 6±8 mg per ml SDS, with a diminished effect in most cultures at 12.5 mg per ml (Fig 3B) . By 25 mg per ml SDS, PAI-2 mRNA and protein sharply declined, concordant with lysis of the cells (see below). In most experiments there was no effect on the differentiation marker involucrin at SDS concentrations from 3 to 25 mg per ml, although some cultures showed a modest increase.
Time courses of the effects on PAI-2 mRNA and protein were determined using 8 mg per ml SDS, which was shown in Fig 3 to be an optimal concentration. In some cultures, after 4 h of incubation there was a small increase in the level of PAI-2 mRNA; however, by 8 h of incubation, there was a consistent dramatic Figure 3 . SDS-mediated induction of PAI-2 in cultured keratinocytes was concentration dependent. Human keratinocytes were incubated in the absence or presence of SDS at 3±12.5 mg per ml. After 16 h of incubation, total RNA was extracted for RNase protection assay of PAI-2 mRNA and, as a reference control, cyclophilin mRNA (A). In parallel experiments, after 24 h of incubation, cell-associated protein was recovered for Western blotting using antibodies to PAI-2 and involucrin (B). Normal human keratinocytes were grown to con¯uence in low Ca 2+ MCDB medium; Ca 2+ was then elevated to 1.0 mM to induce strati®cation and differentiation. After 2 d of incubation, SDS was added at 6 mg per ml (B) or 12.5 mg per ml (C); a control well was not treated with SDS (A). After one more day of incubation, live cells were photographed under phase contrast microscopy. Scale bar: 45 mm.
increase in PAI-2 mRNA, which plateaued at 16 h (Fig 4A) . This plateau was maintained in some cultures until 24 h, but in other cultures PAI-2 mRNA level had started to decline by this time. A small effect on PAI-2 antigen was routinely detected at 8 h and a plateau was reached at 16±24 h (Fig 4B) . These experiments were repeated with keratinocyte cultures initiated from six donors with similar results.
SDS-mediated enhancement of PAI-2 in cultured keratinocytes is not due to induction of nonspeci®c cell lysis SDS is known to exert cytotoxic effects on human epidermal keratinocytes and cell lines (Eun et al, 1994; Brosin et al, 1997) . To determine if the SDS effect on PAI-2 expression in vitro was related to direct cytotoxicity, we performed the following experiments. Examination of SDS-treated cultures by phase contrast microscopy revealed no effect on keratinocyte morphology at low concentrations (i.e., 3 mg per ml). With the addition of 6 mg per ml of SDS, there was a very subtle change, in that some cells appeared slightly more granular and there were occasional foci that exhibited a more irregular intercellular adhesion pattern (Fig 5A, B) . At 12.5 mg per ml SDS, the culture overall had a more refractile appearance, and some of the uppermost cells became elongated, seemingly connected to each other end-to-end ( Fig 4C) . Frankly toxic levels of SDS were reached at concentrations approaching 25 mg per ml, as evidenced by detachment of the cells from the culture dish (data not shown).
As a quantitative measure of SDS toxic effects, we assayed the release of LDH into the culture medium, a well-accepted indicator of cell leakage and lysis. Minimal LDH release (i.e., 2% of maximal) was noted in keratinocyte cultures treated with SDS at concentrations of 10 mg per ml ( Table I) . A small increase in LDH release was noted at 12.5 mg per ml SDS, with a larger increase at 25 mg per ml. Similar results of LDH release assays were reported by van Ruissen et al (1998) . Comparison of the LDH data with Figs 3 and 4 reveals that the induction of PAI-2 expression by SDS was manifest at concentrations that were not toxic; however, the decrease in PAI-2 expression at SDS concentrations of 12.5 mg per ml was most likely due to increasing toxicity.
The effect of SDS on PAI-2 is not due to TNF-a Among the many epidermal effects of barrier disruption is the induction of a number of cytokines, including TNF-a. Induction of TNF-a mRNA and/or antigen was reported in human and mouse epidermis in response to tape-stripping or acetone (Wood et al, 1992; Nickoloff, 1994; Tsai et al, 1994) . Furthermore, TNF-a mRNA was induced in mouse keratinocyte culture in response to SDS (Lisby et al, 1995) . TNF-a has been associated with in¯ammation and is a well-known inducer of PAI-2 in many cell types, including keratinocytes (Wang and Jensen, 1998) . Given these ties among PAI-2 and TNF-a and SDS treatment, we considered whether SDS might lead to the enhancement of PAI-2 indirectly through its induction of TNF-a.
Conditioned media from two cultures and lysates from four cultures that had been treated with SDS for 0±24 h were assayed for TNF-a using an ELISA. TNF-a was consistently low in the lysates. In the absence of SDS, cell-associated TNF-a was just at or below the limit of detection (23±30 pg TNF-a per mg total lysate protein). In the presence of SDS, cell-associated TNF-a was elevated modestly, by approximately 2-fold, in two of the four cultures assayed; the other two cultures showed no effect of SDS on TNF-a. TNF-a was not detectable in the conditioned media (limit of detection was 25 pg per ml), in the presence or absence of SDS, consistent with the low level of TNF-a previously reported in conditioned media of normal human keratinocyte cultures (Kock et al, 1990) . In all cultures, we con®rmed by Western blotting that SDS induced PAI-2. These experiments suggested that TNF-a was probably not involved in the SDS enhancement of PAI-2 in vitro, but to address this question in another way we performed the following experiment.
Keratinocyte cultures were treated with SDS in the presence or absence of a neutralizing antibody to TNF-a. No effect of this antibody on the SDS induction of PAI-2 was observed (Fig 6) . As a control, we demonstrated that the anti-TNF-a antibody was able to prevent the effect of exogenously added TNF-a, thereby con®rming the neutralizing activity of the antibody (Fig 6) .
DISCUSSION
SDS is a well-known inducer of experimental irritant contact dermatitis (Tupker et al, 1990; Lee and Maibach, 1995) . The cutaneous effects of SDS and other irritants are probably due to several factors, including barrier disruption with resultant transepidermal water loss (Agner and Serup, 1990; Elias and Feingold, 1994; Elias, 1996) ; collapse of the epidermal Ca 2+ gradient ; induction of in¯ammation (Willis et al, 1993) ; release and/or production of cytokines (Nickoloff, 1994; Wood et al, 1996) ; increased proteolytic activity (Denda et al, 1997) ; and direct metabolic or cytotoxic effects on the living layers of epidermis (Willis et al, 1989; Fartasch et al, 1998) . The relative importance of and the interrelationships among these factors are likely to vary with the dose and duration of SDS exposure, and at present they are not clearly understood. Further understanding of the direct and indirect mechanisms by which irritants such as SDS affect the skin is important for predicting the potential irritant properties of skin care agents and for designing appropriate screens of such compounds.
In this study we have used the SDS irritant contact dermatitis model to study the expression of PAI-2 under perturbed conditions in normal human skin. Our data demonstrate that PAI-2 mRNA and antigen are induced by topical application of SDS to human volunteers. There is a wide variation in the extent of the PAI-2 response in vivo, however, as observed previously for clinical parameters (Lee and Maibach, 1995; Fartasch et al, 1998) . Although Figure 6 . SDS enhancement of PAI-2 was not secondary to induction of TNF-a. Human epidermal keratinocytes were propagated and maintained under low Ca 2+ conditions throughout this experiment in order to maintain the culture as a monolayer and thus allow free access of antibody to all cells. When the culture wells were approximately 35% con¯uent, the medium was changed to MCDB without BPE. The following day, when the cultures were nearly 70% con¯uent, half of the wells were preincubated for 2 h with 10 mg per ml mouse anti-TNF-a inhibitory antibody. SDS (at 4 mg per ml) or recombinant TNF-a (at 50 ng per ml) was then added to the indicated wells, and incubation was continued for 24 h. Western blot analysis was performed on the cell lysates, loading 2 mg total cell protein per lane and detecting with anti-PAI-2 monoclonal antibody.
SDS induced compaction of the stratum corneum and a mild in¯ammatory reaction in all six subjects treated in this study, an increase in PAI-2 was detected only in the four subjects with the most marked histologic changes.
Previous studies have shown that topical application of SDS induces enhanced expression of other molecules, including several enzymes involved in lipid biosynthesis (Grubauer et al, 1987; Elias, 1996) ; adhesion molecules, such as integrins and ICAM-1 (Lindberg et al, 1990; von den Driesch et al, 1995) ; and at least one other proteolytic enzyme inhibitor, SKALP/ela®n (Boelsma et al, 1998; van Ruissen et al, 1998) . It has been convincingly demonstrated that these increases in protein expression must occur by several different mechanisms. For example, many events, including increases in the enzymes involved in lipid biosynthesis, are signaled by barrier disruption and the resulting transepidermal water loss (Grubauer et al, 1987; Elias and Feingold, 1994; Elias, 1996) . Increases in cytokines fall into a different category of responses, however, which are not signaled by transepidermal water loss but rather may be consequent to cellular damage (Denda et al, 1996) . SDS and other irritants also induce epidermal hyperproliferation, and the mechanism of this response appears to be multifaceted. In mouse skin, there is evidence that SDS-induced proliferation is partially related to transepidermal water loss, but that other factors are also involved (Denda et al, 1996) . A study on SDStreated human skin revealed no correlation between the extent of epidermal proliferation and the increase in transepidermal water loss, leading the authors to suggest that the proliferative effect is mediated via direct effects on the keratinocytes, resulting in synthesis or release of mediators (Welzel et al, 1998) .
The idea that SDS may exert some of its cutaneous effects via direct action on the keratinocyte is intriguing and perhaps unexpected. When topically applied, however, SDS penetrates the stratum corneum to the underlying viable keratinocytes and the stroma (Fullerton et al, 1994; Patil et al, 1995) . From one study, in which 1% SDS was applied to human cadaver skin for 24 h, we have calculated that approximately 24 mg per ml SDS was present in the epidermis underlying the application chamber (Fullerton et al, 1994) . In hairless rat skin, after similar treatment, the epidermal concentration of SDS was approximately 1.8 mg per ml (Patil et al, 1995) . Thus the in vivo concentration of SDS is estimated to be about three orders of magnitude higher than the concentrations that we found effective for elicitation of PAI-2 in keratinocyte culture. These estimates of the concentration of SDS to which the epidermal keratinocyte may actually be exposed in vivo are of necessity rather crude, and we do not know what proportions of SDS were trapped in the stratum corneum versus penetrated to the living layers. Nonetheless, the estimates argue that epidermal keratinocytes in vivo may be exposed to a suf®ciently high concentration of SDS for direct effects, including toxic effects as well as increases in PAI-2, of the detergent to be manifest.
Few studies to date have examined the direct effects of SDS on cells in vitro. In a study with human keratinocyte cultures, van Ruissen et al (1998) used northern blot analysis to show that mRNAs for SKALP and involucrin were markedly upregulated by SDS at concentrations similar to what we found effective for PAI-2; however, keratin 1 mRNA was diminished. In mouse keratinocyte cultures, SDS was found to increase TNF-a mRNA (Lisby et al, 1995) . We do not know if the differences between our data and other data with regard to involucrin and TNF-a expression relate to a difference between protein versus mRNA expression, or to a small difference in culture conditions; or, in the case of TNF-a, to a species difference. Nonetheless, in contrast to others' data at the mRNA level, our immunoblots for involucrin and TNF-a reveal only small and inconsistent effects of SDS treatment in vitro. Both of these proteins were elevated in epidermis upon disruption of the barrier in vivo (Tsai et al, 1994; Le et al, 1996) . As shown in Figs 3 and 4 , the in vitro effect of SDS on PAI-2 is consistently manifest at both the mRNA and the protein level. Thus PAI-2 expression in culture, at least under our culture conditions, appears more consistent with the in vivo epidermal response than other in vitro markers. Van Ruissen et al (1998) have argued that SDS and other anionic detergents induce a switch from the normal keratinocyte differentiation program to a regenerative maturation pathway characteristic of a number of physiologic and pathologic states such as wound healing and psoriasis (Mansbridge and Knapp, 1987) . This idea is supported by observations of SDS-induced increases in SKALP, involucrin, keratin 6, and keratin 16 as well as a decrease in keratin 1 (Boelsma et al, 1998; Ekanayake-Mudiyanselage et al, 1998; van Ruissen et al, 1998) . It is possible that PAI-2 may be another component of such a response. There is evidence to suggest that PAI-2 may be enhanced both in psoriatic epidermis (LyonsGiordano et al, 1994) and in keratinocytes involved in reepithelialization of a skin defect (Bechtel et al, 1998) .
The role of PAI-2 during normal epidermal differentiation or during regenerative maturation is presently unclear, but it may be signi®cant that two distinct proteolytic enzyme inhibitors are associated with epidermal perturbation and repair (PAI-2 and SKALP) in vivo and in vitro. Proteolytic enzyme inhibitors may serve to protect the skin against proteinases released or induced during epidermal disruption and the ensuing repair process. SKALP is not present in normal epidermis, but it is strongly induced during in¯ammation; furthermore, SKALP is constitutively present in other strati®ed squamous epithelia (such as esophagus, oral epithelia, and vagina) where in®ltrating leukocytes appear to be physiologic (Schalkwijk et al, 1993; Pfundt et al, 1996) . This distribution and the speci®city of SKALP as an inhibitor of two leukocyte proteinases (elastase and proteinase 3) strongly suggest that SKALP functions to regulate secreted leukocyte proteinases and thus protect epithelia from damage (Schalkwijk et al, 1993; Pfundt et al, 1996) . PAI-2 that is induced during epidermal perturbation may likewise have a protective role. Barrier disruption has been shown to lead to plasminogen activation in the epidermis (Denda et al, 1997) . Treatment with tranexamic acid, which blocks activation of plasminogen at the cell surface (Reinartz et al, 1993) , accelerates barrier restoration, suggesting that the increased proteinase activity is deleterious to recovery (Denda et al, 1997) . It is possible that PAI-2 is a component of the natural control mechanisms designed to regulate the potentially harmful effects of plasminogen activation during repair. One important difference between PAI-2 and SKALP is that the former, but not the latter, is also synthesized by epidermal keratinocytes under resting conditions (Schalkwijk et al, 1993; Risse et al, 2000) . Hence PAI-2 but not SKALP may also have constitutive roles related to normal epidermal differentiation.
